SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-023207
Filing Date
2022-08-16
Accepted
2022-08-16 16:40:12
Documents
48
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 709651
2 ex10-1.htm EX-10.1 156093
3 ex31-1.htm EX-31.1 17869
4 ex31-2.htm EX-31.2 17202
5 ex32-1.htm EX-32.1 7866
  Complete submission text file 0001493152-22-023207.txt   3642594

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vicp-20220630.xsd EX-101.SCH 25122
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vicp-20220630_cal.xml EX-101.CAL 33787
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vicp-20220630_def.xml EX-101.DEF 100767
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vicp-20220630_lab.xml EX-101.LAB 239456
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vicp-20220630_pre.xml EX-101.PRE 187462
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 460505
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

IRS No.: 621153426 | State of Incorp.: FL
Type: 10-Q | Act: 34 | File No.: 000-56145 | Film No.: 221170669
SIC: 2834 Pharmaceutical Preparations